Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > could it be
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(32)
•••
Comment by Hideawayon Sep 25, 2020 9:14am
211 Views
Post# 31619254

RE:RE:RE:could it be

RE:RE:RE:could it beBikkel, I have spoken with them as well and received similar message.HC is notorious for their slowness and,undoubtedly, some of the blame lies with then.However,considering the urgency for a vaccine as emphasized by the government and the inordinate length of time to reach a conclusion,one has to wonder as to the completeness of the company's submissions.They express frustration but are not at liberty to discuss and if any blame is on their sholders,we will not be so advised.
Seems to be an odd situation,especially considering all the initial enthusiasm months ago,plus having the RSV phase1 knowledge to strengthen our case.
Hope we get good news soon.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities